Persistence and adherence to overactive bladder medications in Japan: A large nationwide real-world analysis.

about

Mirabegron improves quality-of-life, treatment satisfaction, and persistence in patients with overactive bladder: a multi-center, non-interventional, real-world, 12-month study.

P2860

Q47563038-6B2C1869-B0A7-4B5A-A3B3-EED273730BE6

P2860

Persistence and adherence to overactive bladder medications in Japan: A large nationwide real-world analysis.

Item

http://www.wikidata.org/entity/Q38612038

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Persistence and adherence to o ...... ationwide real-world analysis.

@en

type

Item

label

Persistence and adherence to o ...... ationwide real-world analysis.

@en

prefLabel

Persistence and adherence to o ...... ationwide real-world analysis.

@en

P1476

Persistence and adherence to o ...... nationwide real-world analysis

@en

P2093

Alan Fan

http://www.w3.org/2001/XMLSchema#string

Daisuke Kato

http://www.w3.org/2001/XMLSchema#string

James Van Schyndle

http://www.w3.org/2001/XMLSchema#string

Satoshi Uno

http://www.w3.org/2001/XMLSchema#string

P2860

Persistence and compliance with medication management in the treatment of overactive bladder

Persistence and adherence with the new beta-3 receptor agonist, mirabegron, versus antimuscarinics in overactive bladder: Early experience in Canada

Medication compliance and persistence: terminology and definitions.

Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies.

The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis.

Safety, Efficacy, and Persistence of Long-Term Mirabegron Treatment for Overactive Bladder in the Daily Clinical Setting: Interim (1-Year) Report from a Japanese Post-Marketing Surveillance Study.

Persistence in the treatment of overactive bladder syndrome (OAB) with mirabegron in a multicenter clinical study.

Persistence with mirabegron therapy for overactive bladder: A real life experience.

Clinical Guideline for Female Lower Urinary Tract Symptoms.

Clinical guidelines for overactive bladder.

P304

757-764

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/IJU.13422

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tomomi Kimura

P577

2017-08-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28833621

http://www.w3.org/2001/XMLSchema#string

Persistence and adherence to overactive bladder medications in Japan: A large nationwide real-world analysis.

about

P2860

P2860

Persistence and adherence to overactive bladder medications in Japan: A large nationwide real-world analysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698